The Theberge group studies the chemical mechanisms underlying diseases such as bladder infections, prostate cancer, benign prostatic hyperplasia, and asthma. We develop analytical chemistry tools to advance medicine, including biomimetic microfluidic systems for integrated cell culture and small molecule isolation. We collaborate closely with clinicians who treat patients with the diseases that we study and utilize complimentary methods, such as in vivo models, to better understand how chemical processes are linked to patient symptoms.
